• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纯化的破骨细胞通过胶原蛋白的迁移受到基质金属蛋白酶抑制剂的抑制。

The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors.

作者信息

Sato T, Foged N T, Delaissé J M

机构信息

Department of Basic Research, Center for Clinical and Basic Research, Ballerup, Denmark.

出版信息

J Bone Miner Res. 1998 Jan;13(1):59-66. doi: 10.1359/jbmr.1998.13.1.59.

DOI:10.1359/jbmr.1998.13.1.59
PMID:9443791
Abstract

The most obvious proteolytic event controlled by the osteoclast is bone matrix removal in the resorption compartment. Here, however, we investigated whether matrix metalloproteinase (MMP) activity of the osteoclast might be involved in its migration to its future bone resorption site. We seeded either nonpurified or purified osteoclasts onto either uncoated or collagen-coated dentine slices and cultured them in the presence or absence of specific MMP inhibitors. When nonpurified osteoclasts were cultured on uncoated dentine, MMP inhibitors did not prevent pit formation, as previously reported. However, when collagen-coated dentine was used, pit formation was strongly inhibited by MMP inhibitors. The same results were obtained when performing these experiments with purified osteoclasts, thus demonstrating the ability of osteoclasts by themselves to migrate through collagen via an MMP-dependent pathway. This demonstration was confirmed by using collagen-coated invasion chambers. In addition, the invasions were not, or only slightly, inhibited by inhibitors of serine proteinases, cysteine proteinases, and carbonic anhydrase, though the latter two are well established bone resorption inhibitors that strongly inhibited pit formation. It is concluded that osteoclasts can migrate through collagen in the absence of other cells and that this migration relies on MMP activity, whereas other enzymes typically required for bone removal in the resorption compartment are not essential for migration. Some of the osteoclast MMPs might thus be relevant to the migratory/invasive activity of the osteoclast, rather than to its bone resorptive activity itself.

摘要

破骨细胞控制的最明显的蛋白水解事件是在吸收腔中去除骨基质。然而,在此我们研究了破骨细胞的基质金属蛋白酶(MMP)活性是否可能参与其向未来骨吸收位点的迁移。我们将未纯化或纯化的破骨细胞接种到未包被或胶原包被的牙本质切片上,并在存在或不存在特异性MMP抑制剂的情况下进行培养。当未纯化的破骨细胞在未包被的牙本质上培养时,正如先前报道的那样,MMP抑制剂并不能阻止凹坑形成。然而,当使用胶原包被的牙本质时,MMP抑制剂强烈抑制凹坑形成。用纯化的破骨细胞进行这些实验时也得到了相同的结果,从而证明破骨细胞自身有能力通过依赖MMP的途径穿过胶原迁移。使用胶原包被的侵袭小室证实了这一结果。此外,丝氨酸蛋白酶、半胱氨酸蛋白酶和碳酸酐酶的抑制剂对侵袭没有或仅有轻微抑制作用,尽管后两者是公认的骨吸收抑制剂,能强烈抑制凹坑形成。结论是破骨细胞在没有其他细胞的情况下可以穿过胶原迁移,并且这种迁移依赖于MMP活性,而在吸收腔中骨吸收通常所需的其他酶对于迁移并非必需。因此,一些破骨细胞MMP可能与破骨细胞的迁移/侵袭活性有关,而不是与其骨吸收活性本身有关。

相似文献

1
The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors.纯化的破骨细胞通过胶原蛋白的迁移受到基质金属蛋白酶抑制剂的抑制。
J Bone Miner Res. 1998 Jan;13(1):59-66. doi: 10.1359/jbmr.1998.13.1.59.
2
Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.破骨细胞性骨降解以及不同半胱氨酸蛋白酶和基质金属蛋白酶的作用:颅骨与长骨之间的差异
J Bone Miner Res. 2006 Sep;21(9):1399-408. doi: 10.1359/jbmr.060614.
3
The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.半胱氨酸蛋白酶和基质金属蛋白酶对源自长骨和肩胛骨的破骨细胞吸收过程的相对贡献。
Bone. 2004 Oct;35(4):909-17. doi: 10.1016/j.bone.2004.06.002.
4
Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone.半胱氨酸蛋白酶和基质金属蛋白酶在破骨细胞下吸收区发挥不同作用。
J Bone Miner Res. 1998 Sep;13(9):1420-30. doi: 10.1359/jbmr.1998.13.9.1420.
5
MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration.基质金属蛋白酶-9反义寡脱氧核苷酸通过抑制细胞迁移对破骨细胞性骨吸收发挥抑制作用。
Life Sci. 2006 Sep 20;79(17):1657-60. doi: 10.1016/j.lfs.2006.05.024. Epub 2006 Jun 2.
6
Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.基质细胞衍生因子-1(SDF-1)通过诱导趋化作用、基质金属蛋白酶-9(MMP-9)活性和胶原迁移来募集破骨细胞前体。
J Bone Miner Res. 2003 Aug;18(8):1404-18. doi: 10.1359/jbmr.2003.18.8.1404.
7
A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.破骨细胞中基质金属蛋白酶的详细研究:异质性及其他细胞合成基质金属蛋白酶存在的证据
Bone. 2004 Nov;35(5):1107-19. doi: 10.1016/j.bone.2004.06.019.
8
Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases.破骨细胞下方骨吸收区的胶原蛋白降解涉及半胱氨酸蛋白酶和基质金属蛋白酶。
J Cell Physiol. 1992 Feb;150(2):221-31. doi: 10.1002/jcp.1041500202.
9
Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases.人骨髓间充质干细胞来源的成骨细胞在体外通过基质金属蛋白酶降解有机骨基质。
Matrix Biol. 2005 Sep;24(6):438-47. doi: 10.1016/j.matbio.2005.06.009.
10
Matrix metalloproteinases and lysosomal cysteine proteases in osteoclasts contribute to bone resorption through distinct modes of action.
Biochem Biophys Res Commun. 1999 Apr 29;258(1):173-8. doi: 10.1006/bbrc.1999.0473.

引用本文的文献

1
Non-coding RNA modulation in osteoclasts and its implications for osteoblast lineage cell behavior in a co-culture system.破骨细胞中的非编码RNA调控及其在共培养系统中对成骨细胞谱系细胞行为的影响
Cell Commun Signal. 2025 Aug 12;23(1):370. doi: 10.1186/s12964-025-02324-7.
2
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients.自发性破骨细胞生成,晚期腔面A型乳腺癌患者发生骨转移的一个风险因素。
Front Oncol. 2023 Feb 20;13:1073793. doi: 10.3389/fonc.2023.1073793. eCollection 2023.
3
Bone remodeling: an operational process ensuring survival and bone mechanical competence.
骨重塑:一个确保骨骼存活和力学性能的运作过程。
Bone Res. 2022 Jul 18;10(1):48. doi: 10.1038/s41413-022-00219-8.
4
The Mechanism Switching the Osteoclast From Short to Long Duration Bone Resorption.将破骨细胞从短期骨吸收转换为长期骨吸收的机制。
Front Cell Dev Biol. 2021 Mar 30;9:644503. doi: 10.3389/fcell.2021.644503. eCollection 2021.
5
Age-dependent alterations in osteoblast and osteoclast activity in human cancellous bone.年龄依赖性改变在人类松质骨成骨细胞和破骨细胞活性。
J Cell Mol Med. 2017 Nov;21(11):2773-2781. doi: 10.1111/jcmm.13192. Epub 2017 Apr 26.
6
Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis.伴放线聚集杆菌,是牙周宿主防御系统和牙槽骨稳态的强效免疫调节剂。
Mol Oral Microbiol. 2016 Jun;31(3):207-27. doi: 10.1111/omi.12119. Epub 2015 Sep 22.
7
Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.髓系来源的抑制细胞作为新型破骨细胞前体,增强乳腺癌骨丢失。
Cancer Res. 2013 Jan 15;73(2):672-82. doi: 10.1158/0008-5472.CAN-12-2202. Epub 2012 Dec 14.
8
Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo.组织金属蛋白酶抑制剂 3(TIMP-3)在体内调节造血和骨形成。
PLoS One. 2010 Sep 30;5(9):e13086. doi: 10.1371/journal.pone.0013086.
9
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.骨髓微环境在骨髓瘤发生中的作用:其在早期诊断中的潜在作用。
Expert Rev Mol Diagn. 2010 May;10(4):465-80. doi: 10.1586/erm.10.31.
10
Bone cell-matrix protein interactions.
Osteoporos Int. 2009 Jun;20(6):1037-42. doi: 10.1007/s00198-009-0856-7.